Parallel Health

Parallel Health is an American health technology company that develops personalized skin care products. The company was founded by Natalise Kalea Robinson, who serves as chief executive officer, and Nathan Brown, who is chief science officer. It is based in San Francisco, California.

History

Parallel was founded in 2021 to develop phage-based products tailored to individual skin microbiomes.
At its inception, Parallel joined the Illumina Accelerator by Illumina, Inc.
It had raised $2.3 million in pre-seed funding and debuted at TechCrunch Disrupt. In 2022, it was noted in Fast Company’s 'World Changing Ideas' Awards.
In 2024, the company published a paper in The Dermatologist on how testing the skin microbiome and applying phage therapy could successfully engineer a patient’s skin microbiome reduce inflammation and redness.